Investment
 

PuraPharm Corporation Limited
PuraPharm Corporation Limited (stock code 1498) has been listed on the Main Board of The Stock Exchange of Hong Kong Limited since 8 July 2015. PuraPharm is a leading Hong Kong-based Chinese medicine company engaged in the research and development, production, marketing and sale of Concentrated Chinese Medicine Granules ("CCMG") products which PuraPharm markets under its brand "Nong's (�A����)". PuraPharm also sells a broad range of general Chinese healthcare products, examples being PuraGold (���F��) and Oncozac (�w�T��), which are essentially Chinese herbal supplements, on an over-the-counter basis, targeted at end-consumers. PuraPharm is currently the supplier of CCMG products to the Hong Kong Hospital. PuraPharm has also established its own Chinese medicine clinics in Hong Kong under the Nong's (�A����) brand. ENM Group is one of the Pre-IPO investors of PuraPharm and held approximately 4.56% shareholding in PuraPharm after its listing.

Please click here for further information of PuraPharm.

 
© ENM Holdings Limited.